Opportunity Information: Apply for RFA AI 19 025
The U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) is an NIH funding opportunity (RFA-AI-19-025) that supports joint infectious disease research projects carried out through formal collaboration between NIH Intramural Research Program (IRP) scientists and investigators based in South Africa. It uses a cooperative agreement mechanism (U01), meaning NIH expects to have an active scientific partnership role during the project rather than simply providing funds with minimal involvement. Clinical trials are allowed but not required under this announcement ("Clinical Trial Optional"), so applicants can propose either non-clinical or clinical research as long as it fits the program goals.
The scientific scope focuses on high-priority infectious disease areas relevant to both countries and to global health. The FOA specifically highlights research on tuberculosis, sexually transmitted infections, parasitic infections, arboviruses, and emerging or re-emerging viral pathogens. It also explicitly includes vector biology and vector control, which broadens the opportunity beyond pathogen-focused laboratory work to include studies on the organisms that transmit disease (such as mosquitoes and other vectors) and strategies to reduce transmission.
A central requirement is that the project must be genuinely collaborative and balanced across partners. To be eligible, the application has to include at least one NIH IRP investigator serving as a Project Scientist, and that NIH scientist must have an equal role in the conceptualization, design, and execution of the research. In practice, this means the NIH intramural partner cannot be a minor consultant or peripheral contributor; the program is built around shared leadership and integrated scientific effort between NIH intramural laboratories/clinics and the South African research team.
On applicant eligibility, the FOA is structured so that the applying institution is non-U.S. and specifically South African. Non-domestic (non-U.S.) entities and foreign institutions can apply, but only those in South Africa that qualify as National Research Foundations (as defined in the FOA) are eligible to serve as the applicant organization. At the same time, non-domestic components of U.S. organizations are not eligible to apply as the applicant. However, foreign components are allowed under NIH policy, meaning a U.S. organization can have a foreign component involved in the project, but the application itself must meet the FOA's specific eligibility rules about who can be the primary applicant and how the U.S.-South Africa partnership is structured.
Administrative details included in the source information indicate it is an NIH discretionary funding opportunity in the health category (CFDA 93.855), created on March 15, 2019, with an original closing date of July 26, 2019. The listed award ceiling is $250,000. The expected number of awards is not provided in the supplied data. Overall, the opportunity is aimed at sustaining and expanding Phase 2 of an established U.S.-South Africa collaborative program by funding well-integrated teams that can jointly advance biomedical research on major infectious disease threats, with NIH intramural scientists embedded as full partners in the work.Apply for RFA AI 19 025
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (U01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
- This funding opportunity was created on 2019-03-15.
- Applicants must submit their applications by 2019-07-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: International Research Ethics Education and Curriculum Development Award (R25 Clinical Trial Not Allowed)
Previous opportunity: NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA AI 19 025
Applicants also applied for:
Applicants who have applied for this opportunity (RFA AI 19 025) also looked into and applied for these:
| Funding Opportunity |
|---|
| U.S.-South Africa Program for Collaborative Biomedical Research - Phase 2 (Infectious Diseases) (R01 Clinical Trial Optional) Apply for RFA AI 19 024 Funding Number: RFA AI 19 024 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Atopic Dermatitis Research Network -Clinical Research Centers (U01 Clinical Trial Optional) Apply for RFA AI 19 015 Funding Number: RFA AI 19 015 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Institutional Translational Research Training Program (T32) Apply for PAR 19 228 Funding Number: PAR 19 228 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| AHRQ Health Services Research Project: Partners Enabling Diagnostic Excellence (R01) Apply for RFA HS 19 003 Funding Number: RFA HS 19 003 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Informatics Methodology and Secondary Analyses for Immunology Data in ImmPort (UH2 Clinical Trial Not Allowed) Apply for PAR 19 229 Funding Number: PAR 19 229 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Preventive Health and Health Services Block Grant– 2019 Apply for CDC RFA OT19 1902 Funding Number: CDC RFA OT19 1902 Agency: Centers for Disease Control - OSTLTS Category: Health Funding Amount: Case Dependent |
| Development of Sample Sparing Assays for Monitoring Immune Responses (U24 Clinical Trial Not Allowed) Apply for RFA AI 19 017 Funding Number: RFA AI 19 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pragmatic clinical trial on efficacy of managing reduced iron stores on risk of clinically important events in older adults with heart failure and anemia (U01 Clinical Trial Required) Apply for PA 19 230 Funding Number: PA 19 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed) Apply for PAR 19 231 Funding Number: PAR 19 231 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) Apply for RFA RM 19 007 Funding Number: RFA RM 19 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors Early Independence Awards (DP5 Clinical Trial Optional) Apply for RFA RM 19 008 Funding Number: RFA RM 19 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Biomarker Discovery and Novel Point-of-Care Diagnostics for Active TB Disease Detection in HIV-1 Infected and Exposed Children (R01 Clinical Trial Optional) Apply for RFA AI 19 036 Funding Number: RFA AI 19 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30 - Clinical Trial Not Allowed) Apply for PAR 19 232 Funding Number: PAR 19 232 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Targeted Prevention for Tickborne Diseases (R01 Clinical Trial Not Allowed) Apply for RFA AI 19 037 Funding Number: RFA AI 19 037 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) Apply for PAR 19 236 Funding Number: PAR 19 236 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Reducing the Duration of Untreated Psychosis in the United States (R34 Clinical Trial Required) Apply for PAR 19 235 Funding Number: PAR 19 235 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Limited Competition: Additional Sequencing for the Alzheimer's Disease Sequencing Project (U01 Clinical Trial Not Allowed) Apply for PAR 19 234 Funding Number: PAR 19 234 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel RNAs in Virology (including HIV) and Immune Regulation: Basic Science and Therapeutic Discovery (R21 Clinical Trial Not Allowed) Apply for PA 19 237 Funding Number: PA 19 237 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Clinical Research to Improve the Oral Health of Older Adults (R01 Clinical Trial Not Allowed) Apply for PAR 19 239 Funding Number: PAR 19 239 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Clinical Research to Improve the Oral Health of Older Adults (R21 Clinical Trial Not Allowed) Apply for PAR 19 240 Funding Number: PAR 19 240 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 19 025", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.